Surf Bio
Palo Alto
About Surf Bio
Surf Bio is a preclinical biopharmaceutical company leveraging a breakthrough next-generation surfactant to develop enhanced therapeutic solutions for diabetes, oncology, infectious diseases, gene therapy, and other therapeutic areas.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $17.6M
- Funding stage: Seed
- Last round: Grant (Apr 2024)
- Website: surf.bio
Industries & Categories
Biotechnology, Oncology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/surf-bio-31469 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.